Neuroendocrine, neurotransmitter, and gut microbiota imbalance contributing to potential psychiatric disorder prevalence in polycystic ovarian syndrome

被引:4
|
作者
Sarkisian, Karis I. [1 ]
Ho, Lananh [2 ]
Yang, Jane
Mandelbaum, Rachel [1 ]
Stanczyk, Frank Z. [1 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA USA
[2] Univ Rochester, Dept Biomed Engn, Rochester, NY USA
来源
F&S REPORTS | 2023年 / 4卷 / 04期
关键词
Gut-brain axis; neuroendocrine effects; neurotransmitter effects; polycystic ovarian syndrome; psychiatric disorders; PCOS; DEPRESSION; ANXIETY; WOMEN;
D O I
10.1016/j.xfre.2023.08.009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women, affecting up to 15% of reproductive-aged women. Polycystic ovarian syndrome is a heterogeneous disorder, both in the sense that many different factors may play a role in its manifestation and that multiple systems throughout the body can be affected. Polycystic ovarian syndrome has been linked to an increased prevalence of various psychiatric disorders, including depression and anxiety. Despite the socioeconomic effect that these disorders may have on patients with PCOS and society as a whole, this association is largely lacking in research. There are currently several theories regarding the link between PCOS and mental health. Some suggest that the overactive hypothalamic-pituitary- ovarian and hypothalamic-pituitary-adrenal axes in PCOS patients may alter the hormonal profile and contribute to the development of psychiatric disorders. Other studies speculate that abnormal levels of neurotransmitters and neuronal signaling may play a role. Recently, more research has begun to focus on the gut-brain axis, addressing the nutritional needs of PCOS patients. Studies show that dietary factors such as probiotics and micronutrient supplementation may significantly improve psychiatric symptoms in PCOS patients while helping regulate neurotransmitter levels in the body. In this review, we examine different theories regarding the association between PCOS and psychiatric disorders and point out different areas of research that are needed to broaden our understanding of this association. (Fertil Steril Rep (R) 2023;4:337-42. (c) 2023 by American Society for Reproductive Medicine.)
引用
收藏
页码:337 / 342
页数:6
相关论文
共 14 条
  • [1] Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies
    Corrie, Leander
    Awasthi, Ankit
    Kaur, Jaskiran
    Vishwas, Sukriti
    Gulati, Monica
    Kaur, Indu Pal
    Gupta, Gaurav
    Kommineni, Nagavendra
    Dua, Kamal
    Singh, Sachin Kumar
    PHARMACEUTICALS, 2023, 16 (02)
  • [2] Prevalence and characteristics of polycystic ovarian syndrome in patients with bipolar disorder
    Liu, Jieyu
    Teng, Ziwei
    Xie, Haiqing
    Yuan, Hui
    Liu, Minghui
    Chen, Jindong
    Tang, Hui
    Xiang, Hui
    Wu, Haishan
    Huang, Jing
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 340 : 387 - 395
  • [3] Prevalence and Effectiveness of Potential strategies for Polycystic Ovarian Syndrome
    PoornimaAndal, R.
    Kowsalya, S.
    Parthasarathy, Suganya
    VijayaPriya
    JOURNAL OF ADVANCED APPLIED SCIENTIFIC RESEARCH, 2021, 3 (02): : 52 - 64
  • [4] Combination therapy of curcumin and fecal microbiota transplant: Potential treatment of polycystic ovarian syndrome
    Corrie, Leander
    Gulati, Monica
    Vishwas, Sukriti
    Kapoor, Bhupinder
    Singh, Sachin Kumar
    Awasthi, Ankit
    Khursheed, Rubiya
    MEDICAL HYPOTHESES, 2021, 154
  • [5] Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome
    Liang, Z.
    Di, N.
    Li, L.
    Yang, D.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (08) : 1727 - 1737
  • [6] Impact of Buzhong Yiqi Prescription on the Gut Microbiota of Patients with Obesity Manifesting Polycystic Ovarian Syndrome
    Ni, Zhexin
    Cheng, Wen
    Ding, Jie
    Yao, Ruipin
    Zhang, Danying
    Zhai, Dongxia
    Zhou, Ling
    Yu, Chaoqin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [7] Associated Effects of Endocrine Disrupting Chemicals (EDCs) on Neuroendocrine Axes and Neurotransmitter Profile in Polycystic Ovarian Syndrome Condition
    Ananthasubramanian P.
    Ananth S.
    Kumaraguru S.
    Barathi S.
    Santosh W.
    Vasantharekha R.
    Proceedings of the Zoological Society, 2021, 74 (4) : 378 - 386
  • [8] Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of polycystic ovarian syndrome
    Bhandary, Prajna
    Alagundagi, Dhananjay B.
    Shetty, Prasanna Kumar
    Patil, Prakash
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, : 2859 - 2868
  • [9] Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota
    He, Yufeng
    Wang, Qianqian
    Li, Xiu
    Wang, Gang
    Zhao, Jianxin
    Zhang, Hao
    Chen, Wei
    FOOD & FUNCTION, 2020, 11 (06) : 5192 - 5204
  • [10] Mangiferin ameliorates polycystic ovary syndrome in rats by modulating insulin resistance, gut microbiota, and ovarian cell apoptosis
    Yong, Zhang
    Chen, Mimi
    Li, Yingjie
    Guo, Yichen
    Yu, Yansu
    Zhi, Zhou
    Hui, Lu
    Si, Yao
    Wu, Chongming
    Zhang, Xiaopo
    Ning, Ma
    Lu, Weiying
    FRONTIERS IN PHARMACOLOGY, 2024, 15